Skip to main content
. 2022 Aug 8;12:961781. doi: 10.3389/fonc.2022.961781

Table 6.

Comparisons of acute toxicities (grade ≥ 3) between the matched VMAT and tomotherapy groups.

VMAT Tomotherapy p
Mucositis 40.7% (22/54) 22.2% (12/54) 0.038
Dermatitis 5.6% (3/54) 3.7% (2/54) 0.647
Hematologic disorders 25.9% (14/54) 20.4% (11/54) 0.494

VMAT, volumetric modulated arc therapy.